Interleukin-3-mediated regulation of β-catenin in myeloid transformation and acute myeloid leukemia-Reference-Cited by-同舟云学术

Interleukin-3-mediated regulation of β-catenin in myeloid transformation and acute myeloid leukemia

Published:2014-03-05 Issue:1 Volume:96 Page:83-91
ISSN:0741-5400
Container-title:Journal of Leukocyte Biology
language:en
Short-container-title:Journal of Leukocyte Biology

Author:

Sadras Teresa,Perugini Michelle,Kok Chung H.,Iarossi Diana G.,Heatley Susan L.,Brumatti Gabriela,Samuel Michael S.,To Luen B.,Lewis Ian D.,Lopez Angel F.,Ekert Paul G.,Ramshaw Hayley S.,DˈAndrea Richard J.

Funder

National Health and Medical Research Council

Australian postgraduate award

Robinson Institute Postgraduate Scholarship

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Reference43 articles.

1. Giles , F. J. Keating , A. Goldstone , A. H. Avivi , I. Willman , C. L. Kantarjian , H. M. 2002 Hematology Am. Soc. Hematol. Educ. Program

2. Constitutive activation of the Wnt/β-catenin signalling pathway in acute myeloid leukaemia;Simon;Oncogene,2005

3. Expression of β-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis;Ysebaert;Leukemia,2006

4. Prognostic significance of β-catenin and topoisomerase IIα in de novo acute myeloid leukemia;Chen;Am. J. Hematol.,2009

5. Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells;Muller-Tidow;Mol. Cell. Biol.,2004

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mature neurons from iPSCs unveil neurodegeneration-related pathways in mucopolysaccharidosis type II: GSK-3β inhibition for therapeutic potential;Cell Death & Disease;2024-04-29

2. Role of interleukins in acute myeloid leukemia;Leukemia & Lymphoma;2023-06-01

3. CD123 Antagonistic Peptides Assembled with Nanomicelles Act as Monotherapeutics to Combat Refractory Acute Myeloid Leukemia;ACS APPL MATER INTER;2022

4. CD123 Antagonistic Peptides Assembled with Nanomicelles Act as Monotherapeutics to Combat Refractory Acute Myeloid Leukemia;ACS Applied Materials & Interfaces;2022-08-17

5. Expansion of Rare Cancer Cells into Tumoroids for Therapeutic Regimen and Cancer Therapy;Advanced Therapeutics;2021-05-14